GSK plc (GLAXF)

USD 20.85

(0.63%)

Operating Expenses Summary of GSK plc

  • GSK plc's latest annual operating expenses in 2023 was 15.01 Billion GBP , up 6.91% from previous year.
  • GSK plc's latest quarterly operating expenses in 2024 Q1 was 3.44 Billion GBP , down -26.15% from previous quarter.
  • GSK plc reported a annual operating expenses of 13.33 Billion GBP in annual operating expenses 2022, down -18.23% from previous year.
  • GSK plc reported a annual operating expenses of 16.31 Billion GBP in annual operating expenses 2021, up 11.62% from previous year.
  • GSK plc reported a quarterly operating expenses of 3.44 Billion GBP for 2024 Q1, down -26.15% from previous quarter.
  • GSK plc reported a quarterly operating expenses of 5.42 Billion GBP for 2024 Q3, up 42.12% from previous quarter.

Annual Operating Expenses Chart of GSK plc (2023 - 1989)

Historical Annual Operating Expenses of GSK plc (2023 - 1989)

Year Operating Expenses Operating Expenses Growth
2023 15.01 Billion GBP 6.91%
2022 13.33 Billion GBP -18.23%
2021 16.31 Billion GBP 11.62%
2020 14.61 Billion GBP -2.13%
2019 14.93 Billion GBP -1.11%
2018 15.09 Billion GBP -4.19%
2017 15.75 Billion GBP -1.52%
2016 16 Billion GBP 28.39%
2015 12.46 Billion GBP 3.12%
2014 12.08 Billion GBP 0.58%
2013 12.01 Billion GBP -3.1%
2012 12.4 Billion GBP 1.25%
2011 12.24 Billion GBP -28.02%
2010 17.01 Billion GBP 35.45%
2009 12.56 Billion GBP 16.37%
2008 10.79 Billion GBP 6.57%
2007 10.13 Billion GBP -5.0%
2006 10.66 Billion GBP 6.4%
2005 10.02 Billion GBP 1.54%
2004 9.87 Billion GBP -6.19%
2003 10.52 Billion GBP 5.0%
2002 10.02 Billion GBP 0.29%
2001 9.99 Billion GBP -6.59%
2000 10.69 Billion GBP 688.21%
1999 1.35 Billion GBP -64.14%
1998 3.78 Billion GBP -25.56%
1997 5.08 Billion GBP -2.51%
1996 5.21 Billion GBP -24.65%
1995 6.92 Billion GBP 80.07%
1994 3.84 Billion GBP 12.7%
1993 3.41 Billion GBP 21.66%
1992 2.8 Billion GBP -17.49%
1991 3.39 Billion GBP 6.86%
1990 3.17 Billion GBP 23.7%
1989 2.57 Billion GBP 24.82%

Peer Operating Expenses Comparison of GSK plc

Name Operating Expenses Operating Expenses Difference
AstraZeneca PLC 29.57 Billion USD 49.226%
Bristol-Myers Squibb Company PFD CONV 2 17.07 Billion USD 12.026%
CSPC Pharmaceutical Group Limited 2.14 Billion USD -599.5%
Clarus Therapeutics Holdings, Inc. 50.96 Million USD -29364.969%
Novartis AG 24.87 Billion USD 39.616%
PT Kalbe Farma Tbk. 11823.24 Billion USD 99.873%